Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements

Maria Siddiqui; Sergej Konoplev; Ghayas Issa; Hagop Kantarjian; Naval Daver; Farhad Ravandi; Tapan Kadia; Guilin Tang; Sa A. Wang; Beenu Thakral; L. Jeffrey Medeiros; Olga Pozdnyakova; Sherry Pierce; Guillermo Montalban-Bravo; Kelly Chien; Danielle Hammond; Koji Sasaki; Guillermo Garcia-Manero; Robert P. Hasserjian

doi:10.1002/ajh.26858

Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements

Maria Siddiqui, Sergej Konoplev, Ghayas Issa, Hagop Kantarjian, Naval Daver, Farhad Ravandi, Tapan Kadia, Guilin Tang, Sa A. Wang, Beenu Thakral, L. Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Chien, Danielle Hammond, Koji Sasaki, Guillermo Garcia-Manero, Robert P. Hasserjian

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	E91-E94
Journal	American journal of hematology
Volume	98
Issue number	4
DOIs	https://doi.org/10.1002/ajh.26858
State	Published - Apr 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.26858

Cite this

Siddiqui, M., Konoplev, S., Issa, G., Kantarjian, H., Daver, N., Ravandi, F., Kadia, T., Tang, G., Wang, S. A., Thakral, B., Medeiros, L. J., Pozdnyakova, O., Pierce, S., Montalban-Bravo, G., Chien, K., Hammond, D., Sasaki, K., Garcia-Manero, G., & Hasserjian, R. P. (2023). Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology, 98(4), E91-E94. https://doi.org/10.1002/ajh.26858

Siddiqui, M, Konoplev, S, Issa, G , Kantarjian, H , Daver, N , Ravandi, F , Kadia, T , Tang, G , Wang, SA , Thakral, B , Medeiros, LJ, Pozdnyakova, O, Pierce, S, Montalban-Bravo, G , Chien, K, Hammond, D, Sasaki, K , Garcia-Manero, G & Hasserjian, RP 2023, 'Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements', American journal of hematology, vol. 98, no. 4, pp. E91-E94. https://doi.org/10.1002/ajh.26858

@article{b16742110be84d4d8b73c8dea812692c,

title = "Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements",

author = "Maria Siddiqui and Sergej Konoplev and Ghayas Issa and Hagop Kantarjian and Naval Daver and Farhad Ravandi and Tapan Kadia and Guilin Tang and Wang, {Sa A.} and Beenu Thakral and Medeiros, {L. Jeffrey} and Olga Pozdnyakova and Sherry Pierce and Guillermo Montalban-Bravo and Kelly Chien and Danielle Hammond and Koji Sasaki and Guillermo Garcia-Manero and Hasserjian, {Robert P.}",

note = "Funding Information: F.R. has received research funding from Biomea Fusion. The are no other conflicts to declare. ",

year = "2023",

month = apr,

doi = "10.1002/ajh.26858",

language = "English (US)",

volume = "98",

pages = "E91--E94",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements

AU - Siddiqui, Maria

AU - Konoplev, Sergej

AU - Issa, Ghayas

AU - Kantarjian, Hagop

AU - Daver, Naval

AU - Ravandi, Farhad

AU - Kadia, Tapan

AU - Tang, Guilin

AU - Wang, Sa A.

AU - Thakral, Beenu

AU - Medeiros, L. Jeffrey

AU - Pozdnyakova, Olga

AU - Pierce, Sherry

AU - Montalban-Bravo, Guillermo

AU - Chien, Kelly

AU - Hammond, Danielle

AU - Sasaki, Koji

AU - Garcia-Manero, Guillermo

AU - Hasserjian, Robert P.

N1 - Funding Information: F.R. has received research funding from Biomea Fusion. The are no other conflicts to declare.

PY - 2023/4

Y1 - 2023/4

UR - http://www.scopus.com/inward/record.url?scp=85147430292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147430292&partnerID=8YFLogxK

U2 - 10.1002/ajh.26858

DO - 10.1002/ajh.26858

M3 - Letter

C2 - 36661399

AN - SCOPUS:85147430292

SN - 0361-8609

VL - 98

SP - E91-E94

JO - American journal of hematology

JF - American journal of hematology

IS - 4

ER -

Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this